A Single Institution Cost-Comparison of Laparoscopic Versus Open Radical Cystoprostatectomy and Orthotopic Ileal Neobladder

Gregori, Andrea; Bozzola, A.; Simonato, A.; Lissiani, A.; Galli, Stefano; Paoletti, Costanza; Rocco, B.; Scieri, F.; Stener, S.; Gaboardi, Franco

doi:10.1016/s1569-9056(06)61078-6

Cited by 5 publications

(6 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In a cost-analysis study of RALRC versus ORC, Smith, et al19 reported that RALRC is associated with an overall higher financial cost. Gregori, et al20 compared the costs of LRC and ORC and reported that LRC is associated with a reduction in costs compared to the open approach. Therefore, although direct cost comparison analysis between LRC and RALRC is lacking in the literature, it can be indirectly inferred that RALRC is associated with an overall higher financial cost than LRC.…”

Section: Discussionmentioning

confidence: 99%

Pure Laparoscopic Radical Cystectomy with Ileal Conduit: A Single Surgeon's Mid-Term Outcomes

et al. 2013

View full text Add to dashboard Cite

PurposeThe use of laparoscopic radical cystectomy (LRC) for muscle-invasive bladder cancer is not yet widespread because of the technical difficulties of the procedure and the lengthy operating time. In this study, we report a single surgeon's experience with LRC.Materials and MethodsThirty patients (25 men and 5 women) with bladder cancer underwent LRC and ileal conduit by a single surgeon between November 2007 and May 2011. An extracorporeal urinary diversion was performed through 5-6 cm midline incision for specimen extraction.ResultsThe median operating time and estimated blood loss were 527.5 minutes and 275 mL, respectively. There was no conversion to open surgery. The median time to oral intake and postoperative hospital stay were 5 days and 12 days, respectively. The rates of immediate, early postoperative and late postoperative complication were 3.3%, 20% and 20%, respectively. With 16 months of median follow-up, the overall and recurrence-free survival rates were 70% and 56.7%, respectively.ConclusionLRC is feasible for the management of invasive bladder cancer and, with appropriate patient selection, can be a good alternative to open or robot-assisted radical cystectomy in the era of robot-assisted surgery.

show abstract

Section: Discussionmentioning

confidence: 99%

Pure Laparoscopic Radical Cystectomy with Ileal Conduit: A Single Surgeon's Mid-Term Outcomes

et al. 2013

View full text Add to dashboard Cite

show abstract

“…The high cost of materials for the newer technique initially suggested a higher direct cost for RALRC [81][82][83]. However, when complications were considered, cost-identification analysis by Lee et al [84][85][86][87], Martin et al [84][85][86][87], and Gregori et al [84][85][86][87] showed that RALRC was the more cost-efficient option.…”

Section: Economic Evaluationsmentioning

confidence: 99%

“…Lotan and Roehrborn [84][85][86][87] suggested that alternating a bladder tumor marker test with cystoscopy/cytology in the first 2 years would be cost effective provided the cost of the marker was less than $US342 ($US264 in 2002 values). Nam et al [84][85][86][87] found that a modified ImmunoCyt regimen was less expensive than standard cystoscopy/cytology. Lachaine et al [101] estimated that using NMP22 as the follow-up monitoring procedure in the first 6 months of surveillance would be cost effective compared with using cystoscopy/cytology.…”

Section: Economic Evaluationsmentioning

confidence: 99%

The Health Economics of Bladder Cancer: An Updated Review of the Published Literature

2014

View full text Add to dashboard Cite

The purpose of this paper is to provide a current view of the economic burden of bladder cancer, with a focus on the cost effectiveness of available interventions. This review updates a previous systematic review and includes 72 new papers published between 2000 and 2013. Bladder cancer continues to be one of the most common and expensive malignancies. The annual cost of bladder cancer in the USA during 2010 was $US4 billion and is expected to rise to $US5 billion by 2020. Ten years ago, urinary markers held the potential to lower treatment costs of bladder cancer. However, subsequent real-world experiments have demonstrated that further work is necessary to identify situations in which these technologies can be applied in a cost-effective manner. Adjunct cytology remains a part of diagnostic standard of care, but recent research suggests that it is not cost effective due to its low diagnostic yield. Analysis of intravesical chemotherapy after transurethral resection of bladder tumor (TURBT), neo-adjuvant therapy for cystectomy, and robot-assisted laparoscopic cystectomy suggests that these technologies are cost effective and should be implemented more widely for appropriate patients. The existing literature on the cost effectiveness of bladder cancer treatments has improved substantially since 2000. The body of work now includes many new models, registry analyses, and real-world studies. However, there is still a need for new implementation guidelines, new risk modeling tools, and a better understanding of the empirical burden of bladder cancer.

show abstract

“…5,6 Cost comparisons for ORC vs LRC, a relatively novel and potential oncologic equivalent treatment option, are limited to the study results of Gregori and associates. 19 In their study, direct healthcare costs for …”

Section: Discussionmentioning

confidence: 99%

What About Conventional Laparoscopic Radical Cystectomy? Cost-Analysis of Open Versus Laparoscopic Radical Cystectomy

Noel

Leo

2014

Journal of Endourology

View full text Add to dashboard Cite

show abstract

A Single Institution Cost-Comparison of Laparoscopic Versus Open Radical Cystoprostatectomy and Orthotopic Ileal Neobladder

Cited by 5 publications

References 0 publications

Pure Laparoscopic Radical Cystectomy with Ileal Conduit: A Single Surgeon's Mid-Term Outcomes

Pure Laparoscopic Radical Cystectomy with Ileal Conduit: A Single Surgeon's Mid-Term Outcomes

The Health Economics of Bladder Cancer: An Updated Review of the Published Literature

What About Conventional Laparoscopic Radical Cystectomy? Cost-Analysis of Open Versus Laparoscopic Radical Cystectomy

Contact Info

Product

Resources

About